BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 68784)

  • 1. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
    Lampert F; Nitzschke U; Zwergel T
    Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
    Nitzschke U; Zwergel T; Lampert F
    Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the electrophoretic mobility test in children. A diagnostic help in pediatric oncology? (author's transl)].
    Ritter J; Oehme J
    Monatsschr Kinderheilkd (1902); 1978 Sep; 126(9):556-60. PubMed ID: 80743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
    Hoffmann W; Werner W; Steiner R; Kaufmann R
    Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements of the electrophoretic mobility test to measure lymphocyte sensitization.
    Zwergel T; Nitzschke U; Franke F; Lampert F
    Microsc Acta; 1978 Jul; 80(5):383-90. PubMed ID: 692441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characteristics of lymphoblasts and lymphocytes in acute lymphoblastic leukaemia in children.
    Olive D; Sabolovic D; Beugnot MC; Beaugnon M
    Clin Exp Immunol; 1977 Aug; 29(2):220-8. PubMed ID: 269032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 9. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
    Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
    Oncology; 1978; 35(4):163-7. PubMed ID: 81476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concanavalin A receptors on the surface membrane of lymphocytes from patients with Burkitt's lymphoma, other malignant lymphomas, leukaemia and lymphoma cell lines.
    Ben-Bassat H; Goldblum N
    IARC Sci Publ (1971); 1978; (24 Pt 2):639-47. PubMed ID: 751902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
    Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
    Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immune diagnosis of malignant diseases. X. Value of the electrophoresis mobility test in the diagnosis of broncho-pulmonary diseases].
    Douwes FR
    Onkologie; 1978 Apr; 1(2):79-84. PubMed ID: 82241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
    Douwes FR; Hoffmann W; Mross K
    Oncology; 1977; 34(2):80-3. PubMed ID: 70771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lymphocytes in acute lymphoid leukaemia in remission and in relapse. Predictive value of electrophoretic mobility and refringence.
    Sabolovic D; Pompidou A; Amiel JL
    Biomedicine; 1975 Sep; 23(7):283-90. PubMed ID: 1066167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubation.
    Mross K; Mross B; Wolfrum DI; Kohlschütter A
    Res Exp Med (Berl); 1980; 177(3):245-53. PubMed ID: 6160602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the use of the Hemalog D in acute lymphoblastic leukaemia and disseminated non-Hodgkin's lymphoma in children.
    Cranendonk E; Abeling NG; Bakker A; de Jong ME; van Gennip AH; Behrendt H
    Acta Haematol; 1984; 71(1):18-24. PubMed ID: 6419522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.